Nuformix plc (LON:NFX – Get Free Report)’s share price hit a new 52-week low during trading on Thursday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.16 ($0.00), with a volume of 198199 shares traded. The stock had previously closed at GBX 0.17 ($0.00).
Nuformix Stock Performance
The company has a 50-day simple moving average of GBX 0.19 and a two-hundred day simple moving average of GBX 0.25. The company has a quick ratio of 3.35, a current ratio of 1.51 and a debt-to-equity ratio of 1.17. The firm has a market cap of £1.33 million, a PE ratio of -1.63 and a beta of 0.28.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Read More
- Five stocks we like better than Nuformix
- How to Capture the Benefits of Dividend Increases
- BlackBerry Stock: Strong Earnings, Profitability Challenges Ahead
- Dividend Payout Ratio Calculator
- Progress Software Stock Back in the Green After Beating Forecasts
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Goldman Sachs Raises Stock Target for Affirm: Key Insights
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
